Literature DB >> 12476361

Exposure of human lung cells to inhalable substances: a novel test strategy involving clean air exposure periods using whole diluted cigarette mainstream smoke.

Detlef Ritter1, Jan W Knebel, Michaela Aufderheide.   

Abstract

An experimental approach was established for the validation of an in vitro test system for complex environmental test atmospheres consisting of both gaseous substances and particulates. Smoke from two different cigarette types (generated by an automatic cigarette-smoking machine) was employed to assess both the sensitivity and the specificity of the system. The smoke was diluted with synthetic air and used to expose human lung cells grown on microporous membranes. Cells were exposed alternately to diluted cigarette smoke and pure synthetic air. The effect of diluted smoke was assessed without humidification, addition of CO2, or any other physical or chemical modification of the smoke. The experimental setup included online monitoring of the gas phase (by analysis of CO concentration) and particulate phase (by light-scattering photometry). Replicate experiments confirmed a reproducible generation and dilution of the smoke and a smoke age of about 7 s at the time it came into contact with the cells. Experiments using human lung cells revealed that smoke from the two different cigarette types induced different levels of dose-dependent toxicity. A cell exposure of 6 min using 6 alternating smoke and synthetic air periods was sufficient to cause different effects as measured by intracellular glutathione content. The fact that the system could differentiate between two different types of cigarette smoke demonstrated its high sensitivity and specificity. The system offers new ways to test native complex gaseous and aerosol mixtures in vitro using short exposure times and very small amounts of test substances.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12476361     DOI: 10.1080/08958370304449

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  5 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

2.  Regulating temperature and relative humidity in air-liquid interface in vitro systems eliminates cytotoxicity resulting from control air exposures.

Authors:  Jose Zavala; Rebecca Greenan; Q Todd Krantz; David M DeMarini; Mark Higuchi; M Ian Gilmour; Paul A White
Journal:  Toxicol Res (Camb)       Date:  2017-05-23       Impact factor: 3.524

3.  Permeation of Therapeutic Drugs in Different Formulations across the Airway Epithelium In Vitro.

Authors:  Claudia Meindl; Sandra Stranzinger; Neira Dzidic; Sharareh Salar-Behzadi; Stefan Mohr; Andreas Zimmer; Eleonore Fröhlich
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

4.  Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols.

Authors:  Eleonore Fröhlich; Gudrun Bonstingl; Anita Höfler; Claudia Meindl; Gerd Leitinger; Thomas R Pieber; Eva Roblegg
Journal:  Toxicol In Vitro       Date:  2012-08-10       Impact factor: 3.500

Review 5.  Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies.

Authors:  Eleonore Fröhlich; Sharareh Salar-Behzadi
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.